Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors.
| Image |  |
|---|---|
| Description | scientific article published in November 2014 |
| Author/s |
author: Filippo de Braud Sara Pusceddu |
| Publication date | November 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |